283 related articles for article (PubMed ID: 15885078)
1. 5-aminolaevulinic acid photodynamic therapy in a transgenic mouse model of skin melanoma.
Córdoba F; Braathen LR; Weissenberger J; Vallan C; Kato M; Nakashima I; Weis J; von Felbert V
Exp Dermatol; 2005 Jun; 14(6):429-37. PubMed ID: 15885078
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo.
Abels C; Fritsch C; Bolsen K; Szeimies RM; Ruzicka T; Goerz G; Goetz AE
J Photochem Photobiol B; 1997 Aug; 40(1):76-83. PubMed ID: 9301046
[TBL] [Abstract][Full Text] [Related]
3. The role of nitric oxide in the treatment of tumours with aminolaevulinic acid-induced photodynamic therapy.
Reeves KJ; Reed MW; Brown NJ
J Photochem Photobiol B; 2010 Dec; 101(3):224-32. PubMed ID: 20724176
[TBL] [Abstract][Full Text] [Related]
4. A Formulation Study of 5-Aminolevulinic Encapsulated in DPPC Liposomes in Melanoma Treatment.
Lin MW; Huang YB; Chen CL; Wu PC; Chou CY; Wu PC; Hung SY
Int J Med Sci; 2016; 13(7):483-9. PubMed ID: 27429584
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity.
Akita Y; Kozaki K; Nakagawa A; Saito T; Ito S; Tamada Y; Fujiwara S; Nishikawa N; Uchida K; Yoshikawa K; Noguchi T; Miyaishi O; Shimozato K; Saga S; Matsumoto Y
Br J Dermatol; 2004 Aug; 151(2):472-80. PubMed ID: 15327557
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the efficiency of 5-aminolevulinic acid-mediated photodynamic therapy using 5-fluorouracil on human melanoma cells.
Tahmasebi H; Khoshgard K; Sazgarnia A; Mostafaie A; Eivazi MT
Photodiagnosis Photodyn Ther; 2016 Mar; 13():297-302. PubMed ID: 26321747
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of normal and malignant human lymphocytes to 5-aminolevulinic acid-mediated photodynamic damage.
Gamaleia NF; Shishko ED; Gluzman DF; Sklyarenko LM
Exp Oncol; 2008 Mar; 30(1):65-9. PubMed ID: 18438344
[TBL] [Abstract][Full Text] [Related]
8. Synergistic interaction of 5-aminolevulinic acid-based photodynamic therapy with simultaneous hyperthermia in an osteosarcoma tumor model.
Yanase S; Nomura J; Matsumura Y; Nagata T; Fujii T; Tagawa T
Int J Oncol; 2006 Aug; 29(2):365-73. PubMed ID: 16820878
[TBL] [Abstract][Full Text] [Related]
9. The in vitro PDT efficacy of a novel metallophthalocyanine (MPc) derivative and established 5-ALA photosensitizing dyes against human metastatic melanoma cells.
Robertson CA; Abrahamse H; Evans D
Lasers Surg Med; 2010 Dec; 42(10):766-76. PubMed ID: 21246581
[TBL] [Abstract][Full Text] [Related]
10. Optimizing ALA-PDT in the management of non-melanoma skin cancer by fractionated illumination.
De Vijlder HC; Middelburg T; De Bruijn HS; Martino Neumann HA; Sterenborg HC; Robinson DJ; De Haas ER
G Ital Dermatol Venereol; 2009 Aug; 144(4):433-9. PubMed ID: 19755946
[TBL] [Abstract][Full Text] [Related]
11. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic properties of ZnTPPS(4), ClAlPcS(2) and ALA in human melanoma G361 cells.
Krestyn E; Kolarova H; Bajgar R; Tomankova K
Toxicol In Vitro; 2010 Feb; 24(1):286-91. PubMed ID: 19720133
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy using a novel photosensitizer, TONS501, is similarly effective to ALA and EC036 photodynamic therapy on DMBA-and TPA-induced mouse skin papilloma.
Takahashi H; Nakajima S; Asano R; Nakae Y; Sakata I; Iizuka H
J Dermatol Sci; 2012 Jun; 66(3):221-4. PubMed ID: 22464765
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy of murine colon cancer and melanoma using systemic aminolevulinic acid as a photosensitizer.
Haddad R; Kaplan O; Greenberg R; Siegal A; Skornick Y; Kashtan H
Int J Surg Investig; 2000; 2(3):171-8. PubMed ID: 12678516
[TBL] [Abstract][Full Text] [Related]
15. A new method for photodynamic therapy of melanotic melanoma -- effects of depigmentation with violet light photodynamic therapy.
Ma LW; Nielsen KP; Iani V; Moan J
J Environ Pathol Toxicol Oncol; 2007; 26(3):165-72. PubMed ID: 18197832
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of topical ALA-PDT combined with excision in the treatment of skin malignant tumor.
Lu YG; Wang YY; Yang YD; Zhang XC; Gao Y; Yang Y; Zhang JB; Li GL
Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):122-6. PubMed ID: 24568889
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
18. The influence of photodynamic therapy with 5-aminolevulinic acid on senescent skin cancer cells.
Grigalavicius M; Juraleviciute M; Kwitniewski M; Juzeniene A
Photodiagnosis Photodyn Ther; 2017 Mar; 17():29-34. PubMed ID: 27777143
[TBL] [Abstract][Full Text] [Related]
19. 5-Aminolevulinic acid photodynamic therapy of transplantable colon adenocarcinoma in BALB/c mice.
Ziółkowski P; Symonowicz K; Osiecka BJ; Rabczyński J
Arch Immunol Ther Exp (Warsz); 1998; 46(5):301-4. PubMed ID: 9832069
[TBL] [Abstract][Full Text] [Related]
20. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial.
de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ; de Haas ER
Acta Derm Venereol; 2012 Nov; 92(6):641-7. PubMed ID: 22964973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
